Lakefront Biotherapeutics (LKFT) Cash & Equivalents Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) Cash & Equivalents Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 23.81% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 71.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn | -97.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.97% |
| Dec 31, 2025 | 36.78% |
| Sep 30, 2025 | -8.65% |
| Mar 31, 2025 | -7.32% |
| Dec 31, 2024 | -61.49% |
| Sep 30, 2024 | 1,994.93% |
| Mar 31, 2024 | 2,766.15% |
| Dec 31, 2023 | -67.17% |
| Mar 31, 2023 | -90.10% |
| Dec 31, 2022 | -77.25% |
| Dec 31, 2021 | 4.60% |
| Jun 30, 2021 | 10.84% |
| Dec 31, 2020 | 14.70% |
| Jun 30, 2020 | 107.70% |
| Mar 31, 2020 | 124.35% |
| Dec 31, 2019 | 44.22% |
| Sep 30, 2019 | 228.61% |
| Jun 30, 2019 | -15.15% |
| Mar 31, 2019 | -12.99% |
| Dec 31, 2018 | -11.59% |